Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-16 Sale | 2024-02-16 9:13 pm | Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer | 3,939 | $1.08 | $4,254 | 751,597 (Direct) | View |
| 2023-10-30 Sale | 2023-10-31 9:39 pm | Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer | 4,066 | $1.35 | $5,489 | 215,383 (Direct) | View |
| 2021-05-10 Sale | 2021-05-12 5:06 pm | Flexion Therapeutics Inc | FLXN | Arkowitz David Chief Financial Officer | 2,229 | $7.23 | $16,116 | 220,719 (Direct) | View |
| 2021-01-05 Sale | 2021-01-07 5:50 pm | Flexion Therapeutics Inc | FLXN | Arkowitz David Chief Financial Officer | 6,073 | $11.13 | $67,592 | 151,048 (Direct) | View |
| 2020-05-07 Sale | 2020-05-11 4:11 pm | Flexion Therapeutics Inc | FLXN | Arkowitz David Chief Financial Officer | 2,413 | $10.88 | $26,253 | 117,068 (Direct) | View |
| 2020-01-03 Sale | 2020-01-07 4:31 pm | Flexion Therapeutics Inc | FLXN | Arkowitz David Chief Financial Officer | 3,095 | $0 | $0 | 88,481 (Direct) | View |
| 2019-05-31 Purchase | 2019-06-03 4:18 pm | Flexion Therapeutics Inc | FLXN | Arkowitz David Chief Financial Officer | 2,500 | $11.05 | $27,627 | 89,424 (Direct) | View |
| 2019-05-13 Purchase | 2019-05-15 4:05 pm | Flexion Therapeutics Inc | FLXN | Arkowitz David Chief Financial Officer | 4,000 | $11.99 | $47,960 | 86,924 (Direct) | View |
| 2019-05-08 Sale | 2019-05-09 4:32 pm | Flexion Therapeutics Inc | FLXN | Arkowitz David Chief Financial Officer | 2,248 | $10.06 | $22,615 | 82,924 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-15 Exercise | 2024-02-16 9:13 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer | 10,625 | $0 | 751,597 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 9:13 pm | N/A 2034-02-13 | Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer | 537,280 | $0 | 751,597 (Direct) | View |
| 2023-10-27 Exercise | 2023-10-31 9:39 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer | 13,209 | $0 | 215,383 (Direct) | View |
| 2023-04-27 Option Award | 2023-10-31 9:39 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer | 26,418 | $0 | 215,383 (Direct) | View |
| 2023-04-27 Option Award | 2023-05-01 4:43 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer | 42,500 | $0 | 166,613 (Direct) | View |
| 2023-04-12 Option Award | 2023-04-14 4:06 pm | N/A 2033-04-11 | KINETA INC. | KA | Arkowitz David Director | 32,500 | $0 | 32,500 (Direct) | View |
| 2023-03-08 Disposition | 2023-03-09 09:10 am | N/A 2031-06-04 | F-star Therapeutics Inc. | FSTX | Arkowitz David Director | 40,000 | $0 | 0 (Direct) | View |
| 2023-03-08 Equity Swap | 2023-03-09 09:10 am | N/A N/A | F-star Therapeutics Inc. | FSTX | Arkowitz David Director | 8,386 | $7.12 | 0 (Direct) | View |
| 2020-11-20 Other | 2023-03-09 09:10 am | N/A 2025-03-30 | F-star Therapeutics Inc. | FSTX | Arkowitz David Director | 45,886 | $0 | 0 (Direct) | View |
| 2023-02-03 Option Award | 2023-02-07 5:44 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer | 127,500 | $0 | 127,500 (Direct) | View |
| 2022-06-15 Exercise | 2022-10-31 6:05 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer | 5,000 | $0 | 112,992 (Direct) | View |
| 2022-10-27 Option Award | 2022-10-31 6:05 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer | 42,500 | $0 | 112,992 (Direct) | View |
| 2022-07-05 Option Award | 2022-07-06 7:23 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer | 63,492 | $3.15 | 65,492 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 5:06 pm | N/A 2032-06-17 | F-star Therapeutics Inc. | FSTX | Arkowitz David Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-02-04 Option Award | 2022-02-08 9:30 pm | N/A 2032-02-03 | Seres Therapeutics Inc. | MCRB | Arkowitz David See Remarks | 190,000 | $0 | 190,000 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-07 4:03 pm | N/A 2031-06-04 | F-star Therapeutics Inc. | FSTX | Arkowitz David Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 4:05 pm | N/A 2031-06-01 | YUMANITY THERAPEUTICS INC. | YMTX | Arkowitz David Director | 14,800 | $0 | 14,800 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-01 9:25 pm | N/A 2031-05-31 | Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer | 275,000 | $0 | 275,000 (Direct) | View |
Ownership | 2021-06-01 9:14 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer | 0 | $0 | 2,000 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 6:26 pm | N/A 2031-02-28 | Flexion Therapeutics Inc | FLXN | Arkowitz David Chief Financial Officer | 91,900 | $0 | 242,948 (Direct) | View |
| 2020-12-22 Option Award | 2020-12-28 7:05 pm | N/A N/A | YUMANITY THERAPEUTICS INC. | YMTX | Arkowitz David Director | 4,347 | $23 | 4,347 (Direct) | View |
| 2020-11-19 Other | 2020-11-23 11:16 am | 2017-05-24 2021-11-23 | F-star Therapeutics Inc. | SBPH | Arkowitz David Director | 1,096 | $0 | 0 (Direct) | View |
| 2020-07-16 Option Award | 2020-07-20 9:33 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Arkowitz David Chief Financial Officer | 38,750 | $0 | 157,121 (Direct) | View |
| 2020-06-29 Option Award | 2020-07-01 5:22 pm | N/A 2030-06-29 | PROTEOSTASIS THERAPEUTICS INC. | PTI | Arkowitz David Director | 17,400 | $0 | 17,400 (Direct) | View |
| 2020-06-24 Option Award | 2020-06-25 4:00 pm | N/A 2030-06-23 | Spring Bank Pharmaceuticals Inc. | SBPH | Arkowitz David Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2020-06-22 Option Award | 2020-06-24 4:21 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Arkowitz David Chief Financial Officer | 1,303 | $10.83 | 118,371 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-03 4:14 pm | N/A 2030-03-01 | Flexion Therapeutics Inc | FLXN | Arkowitz David Chief Financial Officer | 46,500 | $0 | 134,981 (Direct) | View |
| 2019-12-31 Option Award | 2020-01-02 5:07 pm | N/A N/A | Spring Bank Pharmaceuticals Inc. | SBPH | Arkowitz David Director | 9,098 | $0 | 37,929 (Direct) | View |
| 2019-09-30 Option Award | 2019-10-01 4:45 pm | N/A N/A | Spring Bank Pharmaceuticals Inc. | SBPH | Arkowitz David Director | 4,179 | $0 | 28,831 (Direct) | View |
| 2019-07-10 Option Award | 2019-07-11 08:52 am | N/A 2029-07-09 | Spring Bank Pharmaceuticals Inc. | SBPH | Arkowitz David Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2019-06-28 Option Award | 2019-07-01 08:58 am | N/A N/A | Spring Bank Pharmaceuticals Inc. | SBPH | Arkowitz David Director | 3,896 | $0 | 24,652 (Direct) | View |
| 2019-06-21 Option Award | 2019-06-24 4:10 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Arkowitz David Chief Financial Officer | 2,152 | $9.81 | 91,576 (Direct) | View |